These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 25589192)
21. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450 [TBL] [Abstract][Full Text] [Related]
22. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Maas M; Nelemans PJ; Valentini V; Das P; Rödel C; Kuo LJ; Calvo FA; García-Aguilar J; Glynne-Jones R; Haustermans K; Mohiuddin M; Pucciarelli S; Small W; Suárez J; Theodoropoulos G; Biondo S; Beets-Tan RG; Beets GL Lancet Oncol; 2010 Sep; 11(9):835-44. PubMed ID: 20692872 [TBL] [Abstract][Full Text] [Related]
23. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. Gelber RD; Goldhirsch A; Cole BF; Wieand HS; Schroeder G; Krook JE J Natl Cancer Inst; 1996 Aug; 88(15):1039-45. PubMed ID: 8683634 [TBL] [Abstract][Full Text] [Related]
24. Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer. Jalil O; Claydon L; Arulampalam T J Gastrointest Cancer; 2015 Sep; 46(3):219-36. PubMed ID: 26133151 [TBL] [Abstract][Full Text] [Related]
25. Preoperative short-course radiotherapy (5 × 5 Gy) with delayed surgery versus preoperative long-course radiotherapy for locally resectable rectal cancer: a meta-analysis. Qiaoli W; Yongping H; Wei X; Guoqiang X; Yunhe J; Qiuyan L; Cheng L; Mengling G; Jiayi L; Wei X; Yi Y Int J Colorectal Dis; 2019 Dec; 34(12):2171-2183. PubMed ID: 31745621 [TBL] [Abstract][Full Text] [Related]
26. Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer. Park IJ; Kim DY; Kim HC; Kim NK; Kim HR; Kang SB; Choi GS; Lee KY; Kim SH; Oh ST; Lim SB; Kim JC; Oh JH; Kim SY; Lee WY; Lee JB; Yu CS Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):540-7. PubMed ID: 26068489 [TBL] [Abstract][Full Text] [Related]
27. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer]. Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150 [TBL] [Abstract][Full Text] [Related]
28. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925 [TBL] [Abstract][Full Text] [Related]
29. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose. Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881 [TBL] [Abstract][Full Text] [Related]
30. Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis. Liu SX; Zhou ZR; Chen LX; Yang YJ; Hu ZD; Zhang TS Asian Pac J Cancer Prev; 2015; 16(14):5755-62. PubMed ID: 26320447 [TBL] [Abstract][Full Text] [Related]
31. Postoperative adjuvant radio(chemo)therapy for rectal cancer: an appraisal. Scandolaro L; Cazzaniga LF; Bianchi E; Cagna E; Prina M; Valli MC; Barsacchi L; Frigerio M Tumori; 2004; 90(2):208-15. PubMed ID: 15237584 [TBL] [Abstract][Full Text] [Related]
32. Use of adjuvant, preoperative chemo-radiotherapy in patients with locally advanced rectal cancer. Platell C; Cassidy B; Heywood J; Claringbold P ANZ J Surg; 2002 Sep; 72(9):639-42. PubMed ID: 12269914 [TBL] [Abstract][Full Text] [Related]
33. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy]. You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061 [TBL] [Abstract][Full Text] [Related]
34. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Blanchard P; Lee A; Marguet S; Leclercq J; Ng WT; Ma J; Chan AT; Huang PY; Benhamou E; Zhu G; Chua DT; Chen Y; Mai HQ; Kwong DL; Cheah SL; Moon J; Tung Y; Chi KH; Fountzilas G; Zhang L; Hui EP; Lu TX; Bourhis J; Pignon JP; Lancet Oncol; 2015 Jun; 16(6):645-55. PubMed ID: 25957714 [TBL] [Abstract][Full Text] [Related]
35. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis. Luna-Pérez P; Rodríguez-Ramírez S; Hernández-Pacheco F; Gutiérrez De La Barrera M; Fernández R; Labastida S J Surg Oncol; 2003 Jan; 82(1):3-9. PubMed ID: 12501163 [TBL] [Abstract][Full Text] [Related]
36. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104 [TBL] [Abstract][Full Text] [Related]
37. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174 [TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer. Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057 [TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. Fu XL; Fang Z; Shu LH; Tao GQ; Wang JQ; Rui ZL; Zhang YJ; Tian ZQ Oncotarget; 2017 May; 8(21):34340-34351. PubMed ID: 28423720 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]